<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21820">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02822820</url>
  </required_header>
  <id_info>
    <org_study_id>03</org_study_id>
    <nct_id>NCT02822820</nct_id>
  </id_info>
  <brief_title>The Comparison of Conventional and Advanced Bipolar Energy Modalities During Laparoscopic Staging Surgery of Gynecologic Cancers</brief_title>
  <official_title>The Impact of Bipolar Energy Modalities on Peri-operative Outcome During Laparoscopic Staging Surgery of Gynecologic Cancers: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara University</source>
  <brief_summary>
    <textblock>
      This single-institution prospective randomized clinical trial will be performed at the
      Gynecologic Oncology clinic of Ankara University. Patients with endometrial cancer and
      cervix cancer who will be operated for staging via laparoscopic approach will be included in
      the study. The included patients will be randomized to two groups before surgery. During the
      operation of first group instruments with advanced bipolar energy will be used during
      lymphadenectomy and hysterectomy and salpingo-oophorectomy. In the second group the
      operation will be performed by conventional bipolar energy forceps. The outcome parameters
      to be measured are intra-operative bleeding, duration of operation, intraoperative
      complications, postoperative pain score, postoperative complications, postoperative duration
      of hospitalization, late complications such as lymphocele formation and costs.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of operation</measure>
    <time_frame>six months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Perioperative complications</measure>
    <time_frame>six months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain measured by Visual Analog Scale</measure>
    <time_frame>Postoperative pain scores at 8th and 24th hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cost of hospitalization, operation and complications</measure>
    <time_frame>six months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Perioperative Period</condition>
  <arm_group>
    <arm_group_label>Advanced bipolar (Ligasure-Covidien)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Devices with advanced bipolar energy (Ligasure-Covidien) will be used during laparoscopic hysterectomy and pelvic lymphadenectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional bipolar (RoBi forceps-Karl Storz)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Devices with conventional bipolar energy (RoBi rotating bipolar forceps-Karl Storz) will be used during laparoscopic hysterectomy and pelvic lymphadenectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ligasure-Covidien</intervention_name>
    <description>Vessel sealing device Ligasure-Covidien used during laparoscopic hysterectomy and pelvic lymphadenectomy</description>
    <arm_group_label>Advanced bipolar (Ligasure-Covidien)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RoBi forceps-Karl Storz</intervention_name>
    <description>Vessel sealing device RoBi forceps-Karl Storz used during laparoscopic hysterectomy and pelvic lymphadenectomy</description>
    <arm_group_label>Conventional bipolar (RoBi forceps-Karl Storz)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pathologic diagnosis of endometrial or cervix cancer

          -  Stage I, IB1, IIA1 cervix cancer or patients with partial or complete response to
             chemoradiotherapy

          -  Clinically stage I and II endometrial cancer

        Exclusion Criteria:

          -  Hematologic abnormality

          -  Coagulation disorder

          -  Present or past thromboembolic disease

          -  ECOG performance &gt;2

          -  Advanced stage disease

          -  Fertility preserving surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Salih Taşkın, Assoc Prof</last_name>
    <phone>+903125956405</phone>
    <email>salihtaskin@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ankara University Medical Faculty Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salih Taskin, MD</last_name>
      <phone>+3125957869</phone>
      <email>salihtaskin@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Salih Taskin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 21, 2016</lastchanged_date>
  <firstreceived_date>June 24, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara University</investigator_affiliation>
    <investigator_full_name>salih taskin</investigator_full_name>
    <investigator_title>Assoc. Prof.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
